Mednet Logo

How do you manage Burkitt-type post transplant lymphoproliferative disorder (BL-PTLD)?

Do you routinely incorporate CNS prophylaxis? Does your approach vary based on EBV status, age, or the immunosuppressive regimen being utilized post-transplant?